Overview

An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque Psoriasis

Status:
Recruiting
Trial end date:
2024-04-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of different doses of SYHX1901 tablets in the treatment of moderate to severe plaque psoriasis in order to select doses for further clinical trials.
Phase:
Phase 2
Details
Lead Sponsor:
CSPC Ouyi Pharmaceutical Co., Ltd.